Positive data on Gilead's antiviral treatment This link will open in a new window for COVID-19 emerges from a US NIAID study.
AstraZeneca and Oxford University sign a landmark agreement to develop a COVID-19 vaccine This link will open in a new window, enabling global development, manufacturing and distribution.
AstraZeneca This link will open in a new window also signs a deal with CEPI & Gavi to support the manufacturing, procurement and distribution of 300 million doses.
The COVID-19 death toll surpasses 500,000 This link will open in a new window people globally.